182 related articles for article (PubMed ID: 20510308)
1. Topical treatment of disseminated superficial actinic porokeratosis with hypericin-photodynamic therapy: a case report.
Boiy A; de Witte PA; Roelandts R
Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):123-5. PubMed ID: 20510308
[TBL] [Abstract][Full Text] [Related]
2. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract--a pilot study.
Kacerovská D; Pizinger K; Majer F; Smíd F
Photochem Photobiol; 2008; 84(3):779-85. PubMed ID: 18179625
[TBL] [Abstract][Full Text] [Related]
4. Light and laser treatment modalities for disseminated superficial actinic porokeratosis: a systematic review.
Aird GA; Sitenga JL; Nguyen AH; Vaudreuil A; Huerter CJ
Lasers Med Sci; 2017 May; 32(4):945-952. PubMed ID: 28239750
[TBL] [Abstract][Full Text] [Related]
5. In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin.
Seitz G; Krause R; Fuchs J; Heitmann H; Armeanu S; Ruck P; Warmann SW
Oncol Rep; 2008 Nov; 20(5):1277-82. PubMed ID: 18949433
[TBL] [Abstract][Full Text] [Related]
6. Topical photodynamic therapy in disseminated superficial actinic porokeratosis.
Nayeemuddin FA; Wong M; Yell J; Rhodes LE
Clin Exp Dermatol; 2002 Nov; 27(8):703-6. PubMed ID: 12472551
[TBL] [Abstract][Full Text] [Related]
7. Treatment of disseminated superficial actinic porokeratosis with topical diclofenac gel: a case series.
Vlachou C; Kanelleas AI; Martin-Clavijo A; Berth-Jones J
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1343-5. PubMed ID: 18554227
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin.
Kamuhabwa AR; Huygens A; Roskams T; De Witte PA
Int J Oncol; 2006 Mar; 28(3):775-80. PubMed ID: 16465384
[TBL] [Abstract][Full Text] [Related]
9. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
Höpfner M; Maaser K; Theiss A; Lenz M; Sutter AP; Kashtan H; von Lampe B; Riecken EO; Zeitz M; Scherübl H
Int J Colorectal Dis; 2003 May; 18(3):239-47. PubMed ID: 12673490
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin.
Alecu M; Ursaciuc C; Hãlãlãu F; Coman G; Merlevede W; Waelkens E; de Witte P
Anticancer Res; 1998; 18(6B):4651-4. PubMed ID: 9891535
[TBL] [Abstract][Full Text] [Related]
11. Disseminated superficial actinic porokeratosis associated with topical PUVA.
Allen AL; Glaser DA
J Am Acad Dermatol; 2000 Oct; 43(4):720-2. PubMed ID: 11004640
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of murine fibrosarcoma with topical and systemic administration of hypericin.
Cavarga I; Brezáni P; Cekanová-Figurová M; Solár P; Fedorocko P; Miskovský P
Phytomedicine; 2001 Sep; 8(5):325-30. PubMed ID: 11695874
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
Du HY; Bay BH; Olivo M
Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
[TBL] [Abstract][Full Text] [Related]
14. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
[TBL] [Abstract][Full Text] [Related]
15. Hypericin phototoxicity induces different modes of cell death in melanoma and human skin cells.
Davids LM; Kleemann B; Kacerovská D; Pizinger K; Kidson SH
J Photochem Photobiol B; 2008 May; 91(2-3):67-76. PubMed ID: 18342534
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
Chen B; Zupkó I; de Witte PA
Int J Oncol; 2001 Apr; 18(4):737-42. PubMed ID: 11251168
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.
Kamuhabwa AA; Huygens A; De Witte PA
Int J Oncol; 2003 Nov; 23(5):1445-50. PubMed ID: 14532989
[TBL] [Abstract][Full Text] [Related]
18. Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer.
Du H; Bay BH; Mahendran R; Olivo M
Cancer Lett; 2006 Apr; 235(2):202-8. PubMed ID: 15935550
[TBL] [Abstract][Full Text] [Related]
19. Expression of Y-Box binding protein-1 following hypericin-mediated photodynamic therapy in well-differentiated nasopharyngeal cancer in vivo.
Du HY; Olivo M; Chen YJ; Yip G; Tan PH; Matsumoto K; Tsujimoto M; Bay BH
Int J Mol Med; 2005 Nov; 16(5):865-8. PubMed ID: 16211256
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
Chen B; Roskams T; de Witte PA
Lasers Surg Med; 2002; 31(3):158-63. PubMed ID: 12224088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
